1
ten Berge, Deirdre M.H.J., Damhuis, Ronald A.M., Aerts, Joachim G.J.V., Dingemans, Anne Marie C.
Veröffentlicht in: ten Berge , D M H J , Damhuis , R A M , Aerts , J G J V & Dingemans , A M C 2023 , ' Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands ' , Lung Cancer , vol. 181 , 107253 . https://doi.org/10.1016/j.lungcan.2023.107253;
2023
Veröffentlicht in: ten Berge , D M H J , Damhuis , R A M , Aerts , J G J V & Dingemans , A M C 2023 , ' Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands ' , Lung Cancer , vol. 181 , 107253 . https://doi.org/10.1016/j.lungcan.2023.107253;
2023
Volltext
Weitere Treffer
2
ten Berge, Deirdre M.H.J., Aarts, Mieke J., Groen, Harry J.M., Aerts, Joachim G.J.V., Kloover, Jeroen S.
Veröffentlicht in: ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022
Veröffentlicht in: ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022
Volltext
Weitere Treffer
Suche einschränken
Suchfilter entfernen
Filter aufheben
Datenquelle: BASE - Bielefeld Academic Search Engine
/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
14
name=SDG 3 - Good Health and Well-being
14
Cancer Research
6
Oncology
6
ADENOCARCINOMA
4
AGE
4
ASSOCIATION
4
BRAIN METASTASES
4
CARCINOMAS
4
CELL LUNG-CANCER
4
EGFR
4
FREQUENCY
4
KRAS
4
Netherlands
4
Non-small cell lung cancer
4
PHASE-III
4
THAN 50 YEARS
4
TKI
4
Targeted therapy
4
Young patients
4
Pulmonary and Respiratory Medicine
3